Physician profile
Anthony E Trabue
NPI 1366494775
$1,130.88
in general payments reported to CMS, 2019-2025
15 companies · $14.03 in 2025
The $14.03 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $274 · 2021: $542 · 2022: $177 · 2025: $14.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $345.88 | 2019-2022 | |
| Abbvie INC. | $208.06 | 2019-2022 | |
| Pfizer INC. | $171.50 | 2019-2022 | |
| Daiichi Sankyo INC. | $118.13 | 2019-2022 | |
| Therapeuticsmd, INC. | $60.26 | 2020-2022 | |
| Exeltis, USA INC. | $53.07 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $35.38 | 2021-2022 | |
| Allergan, INC. | $28.86 | 2019 | |
| Ascend Therapeutics US, LLC | $27.20 | 2022 | |
| Mayne Pharma Commercial LLC | $16.79 | 2022 | |
| Aspira Women'S Health INC | $14.50 | 2020 | |
| Agile Therapeutics, INC. | $14.02 | 2021 | |
| Millicent US INC | $13.57 | 2021 | |
| Mylan Pharmaceuticals INC. | $12.23 | 2021 | |
| Evofem Biosciences, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Trabue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.